Stock data
Immunocore Holdings plc (IMCR)
Immunocore Holdings plc (IMCR) reported revenue of US$400.02M and net income of -US$35.51M for fiscal 2025. The figures below come from the company's SEC filings.
Annual results
Data as of 2025-12-31
| Fiscal year | Revenue | Gross profit | Operating income | Net income | Diluted EPS |
|---|---|---|---|---|---|
| 2025 | US$400.02M | — | -US$45.35M | -US$35.51M | — |
| 2024 | US$310.20M | — | -US$70.46M | -US$51.09M | — |
| 2023 | US$249.43M | — | -US$59.65M | -US$55.29M | — |
| 2022 | US$174.36M | — | -US$51.71M | -US$52.54M | — |
| 2021 | US$4.08M | — | -US$174.59M | -US$180.03M | — |
Quarterly results
Data as of 2026-06-30
| Quarter | Revenue | Net income | Diluted EPS |
|---|---|---|---|
| 2026-06-30 | US$115.93M | -US$0.81M | — |
| 2026-03-31 | US$106.68M | US$12.97M | — |
| 2025-12-31 | US$104.48M | -US$30.06M | — |
| 2025-09-30 | US$103.69M | -US$0.18M | — |
| 2025-06-30 | US$97.96M | -US$10.30M | — |
| 2025-03-31 | US$93.88M | US$5.02M | — |
| 2024-12-31 | US$84.05M | -US$23.77M | — |
| 2024-09-30 | US$80.25M | US$8.74M | — |
Sources
- Source: SEC EDGAR company facts
Charts, drawing tools, and the P/E calculator are in the app, free to use.